Upload
emir-cerkezi
View
378
Download
1
Embed Size (px)
Citation preview
8/8/2019 Lipidet Biokimi
1/118
8/8/2019 Lipidet Biokimi
2/118
8/8/2019 Lipidet Biokimi
3/118
8/8/2019 Lipidet Biokimi
4/118
8/8/2019 Lipidet Biokimi
5/118
8/8/2019 Lipidet Biokimi
6/118
1.LIPIDET E THJESHTA
a)vajrat jane estere te acideve yndyrore
me glicerol.(te lenget) b)yndyrnat-estere te acideve te larta yndyrore
me peshe molekulare te larte te alkooleve
monohidroksile(te ngurte).
8/8/2019 Lipidet Biokimi
7/118
2. Lipidet e perbera
a)fosfolipidet
b)glikolipidet
c)lipidet tjera te perbera-sulfolipidet dhe
aminolipidet
3.lipidet e perfituara nga hidroliza e disa
grupeve.Ketu bejne pjese acidet yndyrore
te ngopura dhe te pangopura dhe pasi jane te
paelektrizuara quhen lipide neutrale.
8/8/2019 Lipidet Biokimi
8/118
Glikolipide e thjeshta permbajne
Galaktoze,sfingozine dhe ac.yndyrore
Keta quhen me emrin cerebrozidet. Cerebrozidet ndahen
Kerazin
Cerebron
Nervon
oksinervon
8/8/2019 Lipidet Biokimi
9/118
Vetite e perbashketa te lipideve
a)te patretshem ne uje
b)treten ne tretes jopolar-eter,kloroform,benzen
c)funksion energjetik,ne te treten vitaminat
e tretshme ne yndyrna,funksion mbrojtes d)gjendet shume ne indin nervor-fijet
nervore
8/8/2019 Lipidet Biokimi
10/118
Hipolipoproteinemije
-Abetalipoproteinemija
Mungesa e LDL -Hipobetalipoproteinemia familjare
SASIA E ZVOGLUAR E LDL
-mungesa e alfalipoproteinemi familjare mungesa e HDL
8/8/2019 Lipidet Biokimi
11/118
1.Hiperlipoproteinemia
-mungesa e lipazes lipoproteinike
2.hiperholesterolemi familjare hiperbetalipidemi
3. Hiperlipoproteinemia
disbetalipoproteinemia familjare 4.Hipertriacilglicerolemia familjare-sasi e
madhe e nivelit te VLDL.
8/8/2019 Lipidet Biokimi
12/118
Gangliozidetperbehen nga
Galaktoza +ceramidet +ac.sijalinik
8/8/2019 Lipidet Biokimi
13/118
Lipidet e plazmes se gjakut
Holesteroli
Trigliceridet
VLDL
LDL1
LDL2
LDL
3
HILOMIKRONET
ALBUMINET(INDIDHJAMOR)
8/8/2019 Lipidet Biokimi
14/118
8/8/2019 Lipidet Biokimi
15/118
8/8/2019 Lipidet Biokimi
16/118
8/8/2019 Lipidet Biokimi
17/118
8/8/2019 Lipidet Biokimi
18/118
8/8/2019 Lipidet Biokimi
19/118
8/8/2019 Lipidet Biokimi
20/118
8/8/2019 Lipidet Biokimi
21/118
8/8/2019 Lipidet Biokimi
22/118
8/8/2019 Lipidet Biokimi
23/118
Hyperlipidemia is a major risk factor for both CAD andstroke. Nearly 105 million American adults (49 millionmen and 56 million women) have total blood cholesterollevels (TC) of200 mg/dL or higher, with desirable levels
considered to be below 200 mg/dL.1 Adults with totalcholesterol levels of240 mg/dL or higher are consideredto be at high risk, and those with levels from 200 to 239mg/dL are at borderline-high risk. Of the US adults withelevated TC levels, approximately 37 million have total
blood cholesterol levels of240 mg/dL or higher, placingthem at a higher risk for CAD.1
8/8/2019 Lipidet Biokimi
24/118
ETIO
LOGY
OF
HYPER
LIPIDEMIA
Dietary factors (cholesterol, saturated fatty acids, andobesity) clearly raise the TC level; they are importantcauses of borderline-high cholesterol. Yet there are otherfactors associated with borderline-high LDL cholesterol(LDL-C) levels, including the unexplained decline of LDL-
receptor activity associated with normal aging, the lossof estrogen-stimulated LDL-receptor synthesis aftermenopause, and several genetic defects. With theexception of heterozygous familial hypercholesterolemia(FH), most cases of severe hypercholesterolemia appearto be the result of the coexistence of at least two defectsin LDL metabolism, and as a rule, they can be treatedsuccessfully only by using cholesterol-lowering drugs inhigh doses or in combination.
8/8/2019 Lipidet Biokimi
25/118
Lipoproteins are responsible for transportingcholesterol and other fats through thebloodstream. The two most commonly monitoredare LDLs and HDLs. LDLs carry the largest
amount of cholesterol in the blood and areresponsible for transporting it to extrahepatictissue and depositing it in arterial walls.Conversely, HDLs carry approximately one thirdto one fourth of blood cholesterol. HDLs are
thought to be responsible for transportingcholesterol from the walls of the arteries throughthe bloodstream to the liver for excretion.
8/8/2019 Lipidet Biokimi
26/118
8/8/2019 Lipidet Biokimi
27/118
8/8/2019 Lipidet Biokimi
28/118
What causes hyperlipidemia?
Most hyperlipidemia is caused by lifestyle
habits or treatable medical conditions.Lifestyle contributors include obesity, not
exercising, and smoking. Conditions that
cause hyperlipidemia include diabetes,
kidney disease, pregnancy, and anunderactive thyroid gland.
8/8/2019 Lipidet Biokimi
29/118
8/8/2019 Lipidet Biokimi
30/118
8/8/2019 Lipidet Biokimi
31/118
8/8/2019 Lipidet Biokimi
32/118
CH3CH2CH2CH2CH2CH=CH(CH2)7COOH
acidi linoleik
CH2CH2CH2CH2CH2CH2CH2CH2CH=CH(CH2)7COOH acidi oleik
8/8/2019 Lipidet Biokimi
33/118
8/8/2019 Lipidet Biokimi
34/118
8/8/2019 Lipidet Biokimi
35/118
8/8/2019 Lipidet Biokimi
36/118
8/8/2019 Lipidet Biokimi
37/118
8/8/2019 Lipidet Biokimi
38/118
8/8/2019 Lipidet Biokimi
39/118
8/8/2019 Lipidet Biokimi
40/118
8/8/2019 Lipidet Biokimi
41/118
8/8/2019 Lipidet Biokimi
42/118
8/8/2019 Lipidet Biokimi
43/118
8/8/2019 Lipidet Biokimi
44/118
8/8/2019 Lipidet Biokimi
45/118
Lipoprotein Level Classification
LDL-C < 100 mg/dL-----------------------------Optimal 100-129 mg/dL--------------------------Near or above optimal
130-159 mg/dL---------------------------Borderline high 160-189 mg/dL--------------------------High
> or = 190 mg/dL-----------------------Very high
Total-C or= 240 mg/dL-------------------------High
TG-C: or = 500 mg/dL-----------------------Very high
HDL cholesterol: 60 or = 60 mg/dL--------------------- High
8/8/2019 Lipidet Biokimi
46/118
Nyje limfatike
8/8/2019 Lipidet Biokimi
47/118
8/8/2019 Lipidet Biokimi
48/118
8/8/2019 Lipidet Biokimi
49/118
8/8/2019 Lipidet Biokimi
50/118
8/8/2019 Lipidet Biokimi
51/118
8/8/2019 Lipidet Biokimi
52/118
8/8/2019 Lipidet Biokimi
53/118
8/8/2019 Lipidet Biokimi
54/118
8/8/2019 Lipidet Biokimi
55/118
8/8/2019 Lipidet Biokimi
56/118
8/8/2019 Lipidet Biokimi
57/118
8/8/2019 Lipidet Biokimi
58/118
8/8/2019 Lipidet Biokimi
59/118
8/8/2019 Lipidet Biokimi
60/118
8/8/2019 Lipidet Biokimi
61/118
8/8/2019 Lipidet Biokimi
62/118
8/8/2019 Lipidet Biokimi
63/118
8/8/2019 Lipidet Biokimi
64/118
8/8/2019 Lipidet Biokimi
65/118
8/8/2019 Lipidet Biokimi
66/118
8/8/2019 Lipidet Biokimi
67/118
8/8/2019 Lipidet Biokimi
68/118
8/8/2019 Lipidet Biokimi
69/118
8/8/2019 Lipidet Biokimi
70/118
8/8/2019 Lipidet Biokimi
71/118
8/8/2019 Lipidet Biokimi
72/118
8/8/2019 Lipidet Biokimi
73/118
8/8/2019 Lipidet Biokimi
74/118
8/8/2019 Lipidet Biokimi
75/118
8/8/2019 Lipidet Biokimi
76/118
8/8/2019 Lipidet Biokimi
77/118
8/8/2019 Lipidet Biokimi
78/118
8/8/2019 Lipidet Biokimi
79/118
8/8/2019 Lipidet Biokimi
80/118
8/8/2019 Lipidet Biokimi
81/118
8/8/2019 Lipidet Biokimi
82/118
8/8/2019 Lipidet Biokimi
83/118
8/8/2019 Lipidet Biokimi
84/118
8/8/2019 Lipidet Biokimi
85/118
8/8/2019 Lipidet Biokimi
86/118
8/8/2019 Lipidet Biokimi
87/118
8/8/2019 Lipidet Biokimi
88/118
8/8/2019 Lipidet Biokimi
89/118
8/8/2019 Lipidet Biokimi
90/118
8/8/2019 Lipidet Biokimi
91/118
8/8/2019 Lipidet Biokimi
92/118
8/8/2019 Lipidet Biokimi
93/118
8/8/2019 Lipidet Biokimi
94/118
8/8/2019 Lipidet Biokimi
95/118
8/8/2019 Lipidet Biokimi
96/118
8/8/2019 Lipidet Biokimi
97/118
8/8/2019 Lipidet Biokimi
98/118
8/8/2019 Lipidet Biokimi
99/118
8/8/2019 Lipidet Biokimi
100/118
8/8/2019 Lipidet Biokimi
101/118
8/8/2019 Lipidet Biokimi
102/118
8/8/2019 Lipidet Biokimi
103/118
8/8/2019 Lipidet Biokimi
104/118
8/8/2019 Lipidet Biokimi
105/118
8/8/2019 Lipidet Biokimi
106/118
8/8/2019 Lipidet Biokimi
107/118
8/8/2019 Lipidet Biokimi
108/118
8/8/2019 Lipidet Biokimi
109/118
8/8/2019 Lipidet Biokimi
110/118
8/8/2019 Lipidet Biokimi
111/118
8/8/2019 Lipidet Biokimi
112/118
8/8/2019 Lipidet Biokimi
113/118
8/8/2019 Lipidet Biokimi
114/118
8/8/2019 Lipidet Biokimi
115/118
8/8/2019 Lipidet Biokimi
116/118
8/8/2019 Lipidet Biokimi
117/118
8/8/2019 Lipidet Biokimi
118/118